Synlife

Synlife

Synlife is an R&D biotech company exploring cell-free synthetic biology.

Co-founded by MIT scientists in 2017 and headquartered in Cambridge, MA, Synlife's team is developing therapeutic and diagnostic platforms through bottom-up engineering of synthetic cells. While much of synthetic biology relies on top-down engineering of extant living systems, this strategy is constrained by the fundamental drives of biology, such as evolutionary pressures and resource utilization for the necessary functions of life. By building synthetic minimal cells bottom-up, Synlife can reconstitute desirable functions of biology.

Timeline

2018
Synlife raises a $700,000 seed round.

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
Synlife Seed round, 2018
700,000
2018
1 Result
Results per page:
Page 1 of 1

People

Name
Role
LinkedIn

Ed Boyden

Co-founder

Jeremy Wertheimer

Co-founder

Kate Adamala

Co-founder

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.